Results 11 to 20 of about 49,810 (235)

Peptide immunotherapy in experimental autoimmune encephalomyelitis

open access: yesBiomedical Journal, 2015
We now have potent drugs available to treat the inflammatory component of multiple sclerosis (MS). However, not all patients respond, the drugs are not curative, and the associated risks to beneficial immune surveillance are considerable.
Stephen M Anderton
doaj   +4 more sources

Experimental Autoimmune Encephalomyelitis [PDF]

open access: yes, 2012
Experimental Autoimmune Encephalomyelitis - Models, Disease Biology and Experimental Therapy is totally focused on the model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE).
Amor, S., Baker, D.
core   +7 more sources

Contribution of pannexin1 to experimental autoimmune encephalomyelitis. [PDF]

open access: yesPLoS ONE, 2013
Pannexin1 (Panx1) is a plasma membrane channel permeable to relatively large molecules, such as ATP. In the central nervous system (CNS) Panx1 is found in neurons and glia and in the immune system in macrophages and T-cells. We tested the hypothesis that
Sarah E Lutz   +10 more
doaj   +5 more sources

Experimental Autoimmune Encephalomyelitis [PDF]

open access: yes, 1995
Experimental Autoimmune Encephalomyelitis (EAE) is the prototype for cell-mediated autoimmune disease in general, and is the best animal model of human CNS inflammatory demyelinating disease.
Pender, Michael P.
core   +4 more sources

Immunopathology and Pathophysiology of Experimental Autoimmune Encephalomyelitis [PDF]

open access: yes, 1996
Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system (CNS), and is widely studied as an animal model of the human CNS demyelinating diseases, including multiple sclerosis (Raine, 1984 ...
Pender, Michael P.
core   +4 more sources

Experimental Autoimmune Encephalomyelitis in the Mouse [PDF]

open access: yesCurrent Protocols in Immunology, 1996
AbstractThis unit details the materials and methods required for both active induction and adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in the SJL mouse strain using intact proteins or peptides from the two major myelin proteins: proteolipid protein (PLP) and myelin basic protein (MBP).
Stephen D, Miller, William J, Karpus
openaire   +2 more sources

Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis [PDF]

open access: yes, 2007
Administration of peptide antigens in tolerogenic form holds promise as a specific treatment for autoimmune and allergic disorders. However, experiments in rodent autoimmune models have highlighted the risk of anaphylaxis in response to systemic peptide ...
Stephen M. Anderton   +7 more
core   +1 more source

Amelioration of experimental autoimmune encephalomyelitis by anatabine. [PDF]

open access: yesPLoS ONE, 2013
Anatabine, a naturally occurring alkaloid, is becoming a commonly used human food supplement, taken for its claimed anti-inflammatory properties although this has not yet been reported in human clinical trials.
Daniel Paris   +7 more
doaj   +1 more source

Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18kDa Translocator Protein Radioligand [18F]DPA-714 [PDF]

open access: yes, 2012
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Activated microglia/macrophages play a key role in the immunopathogenesis of MS and its corresponding animal models, experimental autoimmune encephalomyelitis (EAE).
Thézé, Benoit   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy